543 related articles for article (PubMed ID: 18364097)
21. Elevated maternal mid-trimester chorionic gonadotropin > or =4 MoM is associated with fetal cerebral blood flow redistribution.
Hershkovitz R; Erez O; Sheiner E; Landau D; Mankuta D; Mazor M
Acta Obstet Gynecol Scand; 2003 Jan; 82(1):22-7. PubMed ID: 12580835
[TBL] [Abstract][Full Text] [Related]
22. Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein.
Benn PA; Horne D; Briganti S; Rodis JF; Clive JM
Obstet Gynecol; 1996 Feb; 87(2):217-22. PubMed ID: 8559527
[TBL] [Abstract][Full Text] [Related]
23. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
[TBL] [Abstract][Full Text] [Related]
24. Mid-trimester maternal serum markers in predicting adverse pregnancy outcome.
Androutsopoulos G; Gkogkos P; Papadopoulos V; Adonakis G; Tsapanos V; Vassilakos P; Panayiotakis G; Decavalas G
Clin Exp Obstet Gynecol; 2009; 36(4):237-40. PubMed ID: 20101856
[TBL] [Abstract][Full Text] [Related]
25. The value of uterine artery Doppler ultrasound in the prediction of severe complications in a risk population.
Axt-Fliedner R; Schwarze A; Nelles I; Altgassen C; Friedrich M; Schmidt W; Diedrich K
Arch Gynecol Obstet; 2005 Jan; 271(1):53-8. PubMed ID: 15175886
[TBL] [Abstract][Full Text] [Related]
26. Screening for pre-eclampsia by using maternal serum inhibin A, activin A, human chorionic gonadotropin, unconjugated estriol, and alpha-fetoprotein levels and uterine artery Doppler in the second trimester of pregnancy.
Ay E; Kavak ZN; Elter K; Gokaslan H; Pekin T
Aust N Z J Obstet Gynaecol; 2005 Aug; 45(4):283-8. PubMed ID: 16029293
[TBL] [Abstract][Full Text] [Related]
27. First-trimester uterine artery Doppler indices in the prediction of small-for-gestational age pregnancy and intrauterine growth restriction.
Melchiorre K; Leslie K; Prefumo F; Bhide A; Thilaganathan B
Ultrasound Obstet Gynecol; 2009 May; 33(5):524-9. PubMed ID: 19382287
[TBL] [Abstract][Full Text] [Related]
28. The value of uterine artery Doppler in the prediction of uteroplacental complications in multiparous women.
Harrington K; Fayyad A; Thakur V; Aquilina J
Ultrasound Obstet Gynecol; 2004 Jan; 23(1):50-5. PubMed ID: 14971000
[TBL] [Abstract][Full Text] [Related]
29. Uterine artery Doppler in the prediction of adverse pregnancy outcome.
Papageorghiou AT; Leslie K
Curr Opin Obstet Gynecol; 2007 Apr; 19(2):103-9. PubMed ID: 17353676
[TBL] [Abstract][Full Text] [Related]
30. Abnormal second-trimester serum analytes are more predictive of preterm preeclampsia.
Olsen RN; Woelkers D; Dunsmoor-Su R; Lacoursiere DY
Am J Obstet Gynecol; 2012 Sep; 207(3):228.e1-7. PubMed ID: 22818876
[TBL] [Abstract][Full Text] [Related]
31. Mid-trimester maternal serum HCG and alpha fetal protein levels: clinical significance and prediction of adverse pregnancy outcome.
Androutsopoulos G; Gkogkos P; Decavalas G
Int J Endocrinol Metab; 2013; 11(2):102-6. PubMed ID: 23825981
[TBL] [Abstract][Full Text] [Related]
32. Evaluating the thresholds of abnormal second trimester multiple marker screening tests associated with intra-uterine growth restriction.
Odibo AO; Sehdev HM; Stamilio DM; Macones GA
Am J Perinatol; 2006 Aug; 23(6):363-7. PubMed ID: 16841275
[TBL] [Abstract][Full Text] [Related]
33. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler.
Spencer K; Yu CK; Cowans NJ; Otigbah C; Nicolaides KH
Prenat Diagn; 2005 Oct; 25(10):949-53. PubMed ID: 16086443
[TBL] [Abstract][Full Text] [Related]
34. The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications.
Gonen R; Perez R; David M; Dar H; Merksamer R; Sharf M
Obstet Gynecol; 1992 Jul; 80(1):83-6. PubMed ID: 1603504
[TBL] [Abstract][Full Text] [Related]
35. Placental Pathology in Relation to Uterine Artery Doppler Findings in Pregnancies with Severe Intrauterine Growth Restriction and Abnormal Umbilical Artery Doppler Changes.
Levytska K; Higgins M; Keating S; Melamed N; Walker M; Sebire NJ; Kingdom JC
Am J Perinatol; 2017 Apr; 34(5):451-457. PubMed ID: 27649292
[No Abstract] [Full Text] [Related]
36. Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome.
Spencer K
Prenat Diagn; 2000 Aug; 20(8):652-6. PubMed ID: 10951476
[TBL] [Abstract][Full Text] [Related]
37. The role of unexplained high serum alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in the second trimester to determine poor obstetric outcomes.
Öztürk H; Erkaya S; Altınbaş S; Karadağ B; Vanlı Tonyalı N; Özkan D
Turk J Obstet Gynecol; 2014 Sep; 11(3):142-147. PubMed ID: 28913007
[TBL] [Abstract][Full Text] [Related]
38. Unfractionated heparin for second trimester placental insufficiency: a pilot randomized trial.
Kingdom JC; Walker M; Proctor LK; Keating S; Shah PS; McLeod A; Keunen J; Windrim RC; Dodd JM
J Thromb Haemost; 2011 Aug; 9(8):1483-92. PubMed ID: 21689371
[TBL] [Abstract][Full Text] [Related]
39. Prediction of small-for-gestational-age neonates: screening by maternal biochemical markers at 30-34 weeks.
Bakalis S; Gallo DM; Mendez O; Poon LC; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Aug; 46(2):208-15. PubMed ID: 25826797
[TBL] [Abstract][Full Text] [Related]
40. A prospective management study of slow-release aspirin in the palliation of uteroplacental insufficiency predicted by uterine artery Doppler at 20 weeks.
Harrington K; Kurdi W; Aquilina J; England P; Campbell S
Ultrasound Obstet Gynecol; 2000 Jan; 15(1):13-8. PubMed ID: 10776007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
